HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Controversies in the use of portal vein embolization.

AbstractBACKGROUND/AIMS:
Portal vein embolization (PVE) has reached worldwide acceptance to increase future remnant liver (FRL) volume before undertaking major liver resection. The aim of this overview is to point out and discuss current controversies in the application of PVE.
METHODS:
Review of literature pertaining to techniques of PVE, complications, tumor proliferation, timing of resection, and hypertrophy response after PVE.
RESULTS:
Procedure-related complications after PVE include hematoma, hemobilia, overflow of embolization material, and thrombosis of portal vein branch(es) of the non-embolized lobe. Persistence of the embolized, atrophic lobe is usually not harmful. Embolization of the portal branches to segment 4 in addition to embolization of the right portal trunk is controversial and is advised only in selected cases. It remains undecided whether embolization of the portal venous system is more effective in inducing hypertrophy of the FRL than ligation of the portal vein. Accelerated tumor growth after PVE is a major concern and requires consideration of post-PVE chemotherapy. A waiting time of 3 weeks between PVE and liver resection is advised. Post-hepatectomy regeneration is not hampered after preoperative PVE.
CONCLUSION:
PVE is a useful preoperative intervention to increase volume and function of the FRL. Further progress awaits clarification of the mechanisms of the hypertrophy response induced by PVE in conjunction with new embolization materials and protective chemotherapy.
AuthorsThomas M van Gulik, Jacomina W van den Esschert, Wilmar de Graaf, Krijn P van Lienden, Olivier R C Busch, Michal Heger, Otto M van Delden, Johan S Laméris, Dirk J Gouma
JournalDigestive surgery (Dig Surg) Vol. 25 Issue 6 Pg. 436-44 ( 2008) ISSN: 1421-9883 [Electronic] Switzerland
PMID19212116 (Publication Type: Journal Article, Review)
Copyright(c) 2009 S. Karger AG, Basel.
Topics
  • Combined Modality Therapy
  • Embolization, Therapeutic (adverse effects, methods)
  • Female
  • Hepatectomy (methods)
  • Humans
  • Liver Neoplasms (blood supply, mortality, surgery, therapy)
  • Liver Regeneration (physiology)
  • Male
  • Neoplasm Staging
  • Phlebography
  • Portal Vein
  • Preoperative Care (methods)
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Analysis
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: